# DV2-HBV-27: Observational Pregnancy Registry

> **NCT03664648** · — · UNKNOWN · sponsor: **Dynavax Technologies Corporation** · enrollment: 300 (estimated)

## Conditions studied

- Pregnant

## Interventions

- **BIOLOGICAL:** HEPLISAV-B

## Key facts

- **NCT ID:** NCT03664648
- **Lead sponsor:** Dynavax Technologies Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-21
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664648, "DV2-HBV-27: Observational Pregnancy Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03664648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*